0 NASDAQ Companies - March 6, 2024TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdatePresented updated data from ongoing Phase 1 study of TSC-100 and TSC-101 for the treatment of heme malignancies at the […]Read More
0 NASDAQ Companies - March 6, 2024InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update– Record fourth quarter 2023 CGuard EPS revenue of $1.76 million increased 71.6% over fourth quarter 2022 – – Announced […]Read More
0 NASDAQ Companies - March 6, 2024Lantronix Announces Snapdragon 8 Gen 3 Mobile Hardware Development Kit for Qualcomm 8650 System-on-ChipIRVINE, Calif., March 06, 2024 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global provider of compute and connectivity IoT […]Read More
0 NASDAQ Companies - March 6, 2024EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceLYON, France, March 6, 2024 — EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, […]Read More
0 NASDAQ Companies - March 6, 2024Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial ResultsNDA for govorestat accepted and granted Priority Review by FDA for the treatment of Classic Galactosemia; PDUFA target action date […]Read More
0 NASDAQ Companies - March 6, 2024Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory BoardHAIFA, Israel, March 06, 2024 (GLOBE NEWSWIRE) — Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a leading […]Read More
0 NASDAQ Companies - March 6, 2024Haim Shani Concludes Tenure at Cellebrite as Company Enters Next Growth PhaseTYSONS CORNER, Va. and PETAH TIKVA, Israel, March 06, 2024 (GLOBE NEWSWIRE) — Cellebrite DI Ltd. (Nasdaq: CLBT), a leader […]Read More
0 TSX News - March 6, 2024Medicenna to Provide Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming American Association for Cancer Research Annual MeetingTORONTO and HOUSTON, March 06, 2024 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage […]Read More
0 NYSE Companies - March 6, 2024ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024LAUSANNE, Switzerland, March 06, 2024 (GLOBE NEWSWIRE) — ADC Therapeutics SA (NYSE: ADCT) today announced that it will host a […]Read More
0 Canadian Stock Exchange News - March 6, 2024AYR Cannabis Dispensary Celebrates Opening of Relocated Tallahassee Retail LocationMIAMI, March 06, 2024 (GLOBE NEWSWIRE) — AYR Cannabis Dispensary, a cannabis retail chain owned by AYR Wellness Inc. (CSE: […]Read More